Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
December 31, 2024 31.37%
September 30, 2024 39.40%
June 30, 2024 32.83%
March 31, 2024 39.61%
December 31, 2023 41.18%
September 30, 2023 36.66%
June 30, 2023 37.19%
March 31, 2023 37.63%
December 31, 2022 39.37%
September 30, 2022 35.79%
June 30, 2022 34.90%
March 31, 2022 37.51%
December 31, 2021 33.95%
September 30, 2021 46.08%
June 30, 2021 40.02%
March 31, 2021 44.95%
December 31, 2020 23.94%
September 30, 2020 21.90%
June 30, 2020 -7.60%
March 31, 2020 36.19%
December 31, 2019 39.99%
September 30, 2019 44.48%
June 30, 2019 44.88%
March 31, 2019 44.88%
December 31, 2018 47.63%
Date Value
September 30, 2018 48.64%
June 30, 2018 47.95%
March 31, 2018 48.97%
December 31, 2017 48.94%
September 30, 2017 50.96%
June 30, 2017 47.59%
March 31, 2017 52.07%
December 31, 2016 59.44%
September 30, 2016 59.96%
June 30, 2016 53.70%
March 31, 2016 41.07%
December 31, 2015 43.23%
September 30, 2015 48.79%
June 30, 2015 46.70%
March 31, 2015 49.42%
December 31, 2014 51.49%
September 30, 2014 51.53%
June 30, 2014 50.58%
March 31, 2014 53.88%
December 31, 2013 56.32%
September 30, 2013 59.19%
June 30, 2013 59.13%
March 31, 2013 54.21%
December 31, 2012 48.87%
September 30, 2012 57.55%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. 32.53%
Labcorp Holdings, Inc. 27.71%
OPKO Health, Inc. 37.32%
NeoGenomics, Inc. 44.06%
First Choice Healthcare Solutions, Inc. --